Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Hypertension
Clinical trial register · Ireland

Hypertension Trials in Ireland, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Ireland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Alert me on this filter Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 602 matching records held by the registry are in this view. Synced 10 Oct 2026, 03:15 UTC
602
Studies in scope
all four open statuses
305
Recruiting now
open to new participants
167
Lead sponsors
across recruiting studies
3
Irish site locations
across all listed studies
Phase mix of the 305 recruiting studies
Phase 3 94 Not applicable 75 Observational 71 Phase 2 25 Phase 1/2 21 Other 19
Narrow the register Reset
Matches title, registry number, sponsor, intervention and condition.
Recruitment status
Phase
Site location
Galway 4 Dublin 3 Ballinasloe 1
All 3 locations
Target enrolment
to

Hypertension trials in Ireland

6 of 602 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Irish sites
Start
Recruiting
Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
NCT07115953 Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases
Medtronic Vascular
Not applicable
130
Dublin
2025-09-22
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Ballinasloe, Dublin, Galway
2025-07-22
Recruiting
Spyral InSight Study
NCT07013929 Hypertension, Vascular Diseases, Cardiovascular Diseases
Medtronic Vascular
Not applicable
19
Galway
2025-06-09
Recruiting
SPYRAL GEMINI Pilot Study
NCT06907147 Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases
Medtronic Vascular
Not applicable
175
Galway
2025-05-01
Active, closed
SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN
NCT05198674 Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases
Medtronic Vascular
Not applicable
1,899
Dublin
2021-10-20
Active, closed
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
NCT03614260 Hypertension, Vascular Diseases, Cardiovascular Diseases
ReCor Medical, Inc.
Not applicable
224
Galway
2018-12-14
Rows per page Showing 1–6 of 6
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Irish investigative site, filtered. Derived from ClinicalTrials.gov, U.S. National Library of Medicine. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-ireland/condition/hypertension

Query this register directly
GET /api/trials?country=ie&status=recruiting&phase=Phase+3&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Ireland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 602 studies in total at the last sync on 10 Oct 2026, 03:15 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 6 of those studies listing the condition Hypertension.

How many Hypertension trials are recruiting in Ireland?

4 of the 6 studies on this page are recruiting new participants as of the 10 Oct 2026, 03:15 UTC sync. A further 0 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hypertension), 6 studies
PhaseStudiesRecruitingShare
Not applicable5383.3%
Phase 31116.7%

Most active sponsors

Lead sponsors with the most studies (Hypertension)
Lead sponsorStudiesRecruiting
Medtronic Vascular43
Boehringer Ingelheim11
ReCor Medical, Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see the EU Clinical Trials Tracker.